{"id":3170,"date":"2026-04-13T11:38:25","date_gmt":"2026-04-13T11:38:25","guid":{"rendered":"https:\/\/www.inbody.in\/blog\/?p=3170"},"modified":"2026-04-16T04:32:06","modified_gmt":"2026-04-16T04:32:06","slug":"obeda-is-here-but-what-happens-to-your-muscles","status":"publish","type":"post","link":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles","title":{"rendered":"Obeda Is Here, but What Happens to Your Muscles?"},"content":{"rendered":"\n<p>How Body Composition Monitoring Completes the Semaglutide Story in India<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"612\" src=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp\" alt=\"\" class=\"wp-image-3316\" srcset=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp 1024w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet-300x179.webp 300w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet-768x459.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-problem\"><span class=\"ez-toc-section\" id=\"The_Problem_Weight_Doesnt_Tell_the_Whole_Story\"><\/span><strong>The Problem: Weight Doesn&#8217;t Tell the Whole Story<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>GLP-1 therapy conversations typically focus on blood sugar control and body weight reduction. This simplified framework misses what actually governs how your body responds to semaglutide: changes in muscle mass, fat distribution, and cellular metabolic health.<\/strong><\/p>\n\n\n\n<p><strong>The real story is body composition, a complex biological picture that can now be measured precisely through InBody technology. InBody reveals what semaglutide actually does beneath the surface of the scale, not just what you weigh.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"executive-summary\"><span class=\"ez-toc-section\" id=\"Executive_Summary\"><\/span><strong>Executive Summary<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>In this article, you&#8217;ll learn:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Why Obeda is a landmark moment for metabolic health in India<\/strong><\/li>\n\n\n\n<li><strong>How GLP-1 therapy affects muscle mass, not just fat<\/strong><\/li>\n\n\n\n<li><strong>Which InBody parameters must clinicians track on semaglutide therapy<\/strong>?<\/li>\n\n\n\n<li><strong>How to interpret skeletal muscle mass, visceral fat, phase angle, and BMR<\/strong><\/li>\n\n\n\n<li><strong>Why body weight alone misses the critical changes happening inside<\/strong><\/li>\n\n\n\n<li><strong>A step-by-step clinical monitoring protocol using InBody<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-is-obeda\"><span class=\"ez-toc-section\" id=\"What_Is_Obeda_and_Why_Does_It_Matter_for_India\"><\/span><strong>What Is Obeda and Why Does It Matter for India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"834\" src=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Obeda-Injection-1024x834.webp\" alt=\"\" class=\"wp-image-3315\" srcset=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Obeda-Injection-1024x834.webp 1024w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Obeda-Injection-300x244.webp 300w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Obeda-Injection-768x626.webp 768w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Obeda-Injection.webp 1100w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"has-pale-cyan-blue-background-color has-background\"><strong>Launched in March 2026, Obeda is India&#8217;s first DCGI-approved generic semaglutide injection, developed and manufactured entirely in-house by Dr Reddy&#8217;s Laboratories. It is a GLP-1 (glucagon-like peptide-1) receptor agonist, a class of drugs that mimics a naturally occurring gut hormone to regulate blood sugar, suppress appetite, slow gastric emptying, and support weight reduction.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"aioseo-key-facts-about-obeda-18\"><span class=\"ez-toc-section\" id=\"Key_facts_about_Obeda\"><\/span><strong>Key facts about Obeda:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Administered once weekly via a pre-filled, disposable subcutaneous injection pen<\/li>\n\n\n\n<li>Available in 2 mg and 4 mg strengths, each pen delivering a minimum of four weekly doses<\/li>\n\n\n\n<li>Priced at \u20b94,200 per month, making GLP-1 therapy accessible to millions for the first time<\/li>\n\n\n\n<li>Phase III clinical trial in 312 participants confirmed non-inferior efficacy vs. the innovator drug (Ozempic)<\/li>\n\n\n\n<li>Day-1 generic entry launched immediately upon patent expiry in India.<\/li>\n<\/ul>\n\n\n\n<p class=\"has-pale-cyan-blue-background-color has-background\"><strong>101M+ Adults in India living with Type 2 Diabetes (ICMR-INDIAB)<\/strong><br>1<strong>36M Pre-diabetic Indians at high risk of developing the disease<\/strong><br><strong>\u20b94,200 Obeda monthly price, the first affordable GLP-1 access in India<\/strong><\/p>\n\n\n\n<p><strong>India carries one of the world&#8217;s heaviest diabetes burdens. Obeda changes the affordability equation for GLP-1 therapy, and with that, wider access comes greater clinical responsibility for every physician managing metabolic disease.<\/strong><\/p>\n\n\n\n<p><strong>When patients begin semaglutide therapy, body weight falls. HbA1c improves. Patients feel encouraged. Clinicians are satisfied. But beneath that number on the scale, a more complex and sometimes concerning biological story is unfolding.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"the-muscle-problem\"><span class=\"ez-toc-section\" id=\"The_Problem_the_Scale_Cannot_See\"><\/span><strong>The Problem the Scale Cannot See<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Multiple international studies on semaglutide and related GLP-1 drugs have shown that a significant proportion of total weight lost can come from lean muscle mass, not just body fat. In some trials, up to 25\u201340% of total weight lost was lean mass, not fat. For older patients or those with existing sarcopenia, this is clinically significant and entirely invisible on a standard weighing scale.<\/p>\n\n\n\n<p><strong>A standard BMI measurement or weighing scale tells you how much someone weighs. An InBody scan tells you what they are made of and whether therapy is working in the right direction.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"aioseo-key-takeaway-muscle-loss-drives-metabolic-slowdown-31\"><span class=\"ez-toc-section\" id=\"Key_Takeaway_Muscle_Loss_Drives_Metabolic_Slowdown\"><\/span>Key Takeaway: Muscle Loss Drives Metabolic Slowdown<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>When skeletal muscle declines, resting metabolic rate drops and fat storage becomes more efficient. This explains why some patients on GLP-1 therapy may regain weight after stopping their metabolic engine has downshifted due to lean mass loss, not fat.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"what-inbody-measures\"><span class=\"ez-toc-section\" id=\"What_InBody_Measures_and_Why_It_Matters_in_GLP-1_Therapy\"><\/span><strong>What InBody Measures and Why It Matters in GLP-1 Therapy<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1163\" height=\"814\" src=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-GLP-1-Key-metric.webp\" alt=\"\" class=\"wp-image-3320\" srcset=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-GLP-1-Key-metric.webp 1163w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-GLP-1-Key-metric-300x210.webp 300w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-GLP-1-Key-metric-1024x717.webp 1024w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-GLP-1-Key-metric-768x538.webp 768w\" sizes=\"auto, (max-width: 1163px) 100vw, 1163px\" \/><\/figure>\n\n\n\n<p><strong>InBody&#8217;s bioelectrical impedance analysis (BIA) technology delivers a precise, non-invasive, clinic-ready breakdown of body composition in under 60 seconds. For patients on Obeda or any GLP-1 therapy, these are the parameters that matter most:<\/strong><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-skeletal-muscle-mass-smm-36\"><span class=\"ez-toc-section\" id=\"Skeletal_Muscle_Mass_SMM\"><\/span><strong><strong><strong>Skeletal Muscle Mass (SMM)<\/strong><\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Tracks whether patients are preserving or losing muscle alongside fat. Critical for assessing sarcopenic obesity in older adults on GLP-1 therapy.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-body-fat-mass-percentage-38\"><span class=\"ez-toc-section\" id=\"Body_Fat_Mass_Percentage\"><\/span><strong><strong><strong>Body Fat Mass &amp; Percentage<\/strong><\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Confirms therapy is driving true fat reduction, not water or lean mass loss. The definitive marker of quality weight loss.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-visceral-fat-level-40\"><span class=\"ez-toc-section\" id=\"Visceral_Fat_Level\"><\/span><strong><strong><strong>Visceral Fat Level<\/strong><\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Quantifies metabolically dangerous organ fat directly. Critical for cardiovascular and metabolic risk monitoring on semaglutide therapy.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-phase-angle-42\"><span class=\"ez-toc-section\" id=\"Phase_Angle\"><\/span><strong><strong><strong>Phase Angle<\/strong><\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>A marker of cellular health and membrane integrity. Declining phase angle on GLP-1 therapy may signal muscle cell deterioration and trigger intervention.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-basal-metabolic-rate-bmr-44\"><span class=\"ez-toc-section\" id=\"Basal_Metabolic_Rate_BMR\"><\/span><strong><strong><strong>Basal Metabolic Rate (BMR)<\/strong><\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Estimated from fat-free mass, not total weight. Tracks whether resting metabolism is being preserved or reduced during therapy.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-ecw-tbw-ratio-46\"><span class=\"ez-toc-section\" id=\"ECWTBW_Ratio\"><\/span><strong><strong><strong>ECW\/TBW Ratio<\/strong><\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Extracellular-to-total body water ratio. Elevated values may indicate inflammation or fluid imbalance factors that affect metabolic signalling.<\/li>\n\n\n\n<li><strong>These measurements explain what is driving weight change during semaglutide therapy, insight that body weight or BMI cannot provide.<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"insulin-resistance\"><span class=\"ez-toc-section\" id=\"Insulin_Resistance_Visible_Through_Body_Composition\"><\/span><strong>Insulin Resistance Visible Through Body Composition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>One of the earliest metabolic disruptions in type 2 diabetes is insulin resistance. As muscle cells become less responsive to insulin, glucose redirects toward fat storage rather than energy production. InBody reveals this pattern before it worsens.<\/strong><\/p>\n\n\n\n<p><strong>Body composition patterns indicating insulin resistance on InBody:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Increasing body fat mass  especially centrally<\/strong><\/li>\n\n\n\n<li><strong>Elevated visceral fat level in the abdomen<\/strong><\/li>\n\n\n\n<li><strong>Loss of skeletal muscle mass relative to fat mass<\/strong><\/li>\n\n\n\n<li><strong>Declining leg muscle mass, two-thirds of total muscle is in the legs, critical for glucose disposal<\/strong><\/li>\n\n\n\n<li><strong>Reducing BMR despite stable or rising body weight<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>InBody&#8217;s Segmental Lean Analysis tracks limb muscle changes individually, particularly leg muscle, which plays a crucial role in glucose metabolism and insulin sensitivity.<\/strong><\/p>\n\n\n\n<p class=\"has-pale-cyan-blue-background-color has-background\"><strong>Why Leg Muscle Matters for Diabetic Patients<\/strong><br>Skeletal muscle in the legs is the largest glucose disposal site in the body. When leg muscle mass declines, as can happen on GLP-1 therapy without adequate protein or exercise, insulin sensitivity can paradoxically worsen even as body weight falls. InBody&#8217;s segmental analysis is the only way to detect this early.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"visceral-fat\"><span class=\"ez-toc-section\" id=\"Visceral_Fat_The_Hidden_Metabolic_Risk_Semaglutide_Targets\"><\/span><strong>Visceral Fat: The Hidden Metabolic Risk Semaglutide Targets<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"685\" src=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Visceral-Fat-Hidden-Risk.webp\" alt=\"\" class=\"wp-image-3317\" srcset=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Visceral-Fat-Hidden-Risk.webp 1024w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Visceral-Fat-Hidden-Risk-300x201.webp 300w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Visceral-Fat-Hidden-Risk-768x514.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><strong>Fat tissue is biologically active. As fat accumulates around internal organs, it disrupts metabolic signalling, promotes inflammation, and impairs liver and cardiovascular function. This is precisely what semaglutide is designed to reduce and precisely what InBody quantifies.<\/strong><\/p>\n\n\n\n<p><strong>Visceral Fat Level is a critical parameter that standard scales and BMI calculations cannot measure. Higher values associate with:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Impaired liver metabolism and fatty liver disease<\/strong><\/li>\n\n\n\n<li><strong>Poor glucose control and worsening insulin resistance<\/strong><\/li>\n\n\n\n<li><strong>Increased cardiovascular and stroke risk<\/strong><\/li>\n\n\n\n<li><strong>Chronic low-grade inflammation<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Even &#8220;normal&#8221; weight individuals may show elevated visceral fat on InBody analysis, revealing a hidden metabolic risk that BMI cannot detect. Tracking visceral fat reduction over the course of Obeda therapy is one of the most clinically meaningful ways to measure treatment efficacy.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"clinical-protocol\"><span class=\"ez-toc-section\" id=\"A_Suggested_Clinical_Protocol_Obeda_InBody\"><\/span><strong>A Suggested Clinical Protocol: Obeda + InBody<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>For clinicians integrating semaglutide therapy into their practice, the following body composition monitoring protocol provides a best-practice framework. It supports better patient outcomes, justifies clinical decisions, and creates an objective data trail for long-term metabolic management.<\/strong><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-1-baseline-scan-before-starting-obeda-73\"><span class=\"ez-toc-section\" id=\"1_Baseline_Scan_Before_Starting_Obeda\"><\/span><strong><strong>1<\/strong>. <strong>Baseline Scan Before Starting Obeda<\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Conduct an InBody scan before the first dose. Record SMM, body fat %, visceral fat level, phase angle, BMR, and ECW\/TBW ratio. This establishes the patient&#8217;s true metabolic starting point independent of weight alone.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-2-week-46-check-dose-escalation-phase-75\"><span class=\"ez-toc-section\" id=\"2_Week_4%E2%80%936_Check_Dose_Escalation_Phase\"><\/span><strong><strong>2<\/strong>. <strong>Week 4\u20136 Check Dose Escalation Phase<\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Obeda begins at a low dose and is escalated over weeks. An InBody scan at 4\u20136 weeks identifies early disproportionate lean mass loss before it becomes clinically significant, allowing dietary intervention before it progresses.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-3-monthly-monitoring-active-therapy-77\"><span class=\"ez-toc-section\" id=\"3_Monthly_Monitoring_Active_Therapy\"><\/span><strong><strong>3. Monthly Monitoring Active Therapy<\/strong><\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Monthly scans track the quality of weight loss in real time. If fat mass is declining and SMM is stable or increasing, therapy is on track. If both are declining together, a protein and resistance exercise intervention is warranted immediately.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-4-nutritional-adjustment-protein-optimisation-79\"><span class=\"ez-toc-section\" id=\"4_Nutritional_Adjustment_Protein_Optimisation\"><\/span><strong>4. Nutritional Adjustment Protein Optimisation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>InBody data combined with dietary assessment allows targeted protein intake recommendations. Adequate protein (1.2\u20131.6 g\/kg body weight) is critical to preserving muscle mass during GLP-1 therapy, especially as appetite suppression reduces overall food intake.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-5-6-month-outcome-review-81\"><span class=\"ez-toc-section\" id=\"5_6-Month_Outcome_Review\"><\/span><strong>5.<\/strong> <strong>6-Month Outcome Review<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<p>Compare the 6-month InBody report to baseline. Calculate net changes in fat mass and lean mass separately. Use this data to counsel patients on maintenance, exercise programming, and whether dose adjustment is warranted.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"scale-vs-inbody\"><span class=\"ez-toc-section\" id=\"Scale_Weight_vs_InBody_What_Each_One_Sees\"><\/span><strong>Scale Weight vs. InBody: What Each One Sees<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Parameter<\/th><th>Weighing Scale<\/th><th>InBody Analysis<\/th><\/tr><\/thead><tbody><tr><td>Total body weight<\/td><td>Yes<\/td><td>Yes<\/td><\/tr><tr><td>Body fat mass &amp; percentage<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Skeletal muscle mass<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Visceral fat level<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Basal metabolic rate (BMR)<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Phase angle (cellular health)<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>ECW\/TBW (inflammation marker)<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Segmental limb muscle<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Distinguishes fat vs. muscle loss<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Identifies sarcopenic obesity<\/td><td>No<\/td><td>Yes<\/td><\/tr><tr><td>Scan time<\/td><td>Instant<\/td><td>Under 60 seconds<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"aioseo-deepen-your-expertise-in-body-composition-analysis-85\"><span class=\"ez-toc-section\" id=\"Deepen_Your_Expertise_in_Body_Composition_Analysis\"><\/span>Deepen Your Expertise in Body Composition Analysis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Healthcare professionals seeking to master metabolic assessment and body composition science can gain hands-on training at InBody Academia, an intensive learning experience covering clinical interpretation, metabolic risk identification, and practical application of InBody data in real patient care.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"metabolic-adaptation\"><span class=\"ez-toc-section\" id=\"Tracking_Metabolic_Adaptation_Over_a_Course_of_Semaglutide\"><\/span><strong>Tracking Metabolic Adaptation Over a Course of Semaglutide<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>As semaglutide therapy progresses, the body may reduce energy expenditure beyond what size alone would predict, a phenomenon called adaptive thermogenesis. This is especially pronounced when lean mass is lost alongside fat.<\/strong><\/p>\n\n\n\n<p><strong>Serial InBody assessments reveal adaptation through:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Falling BMR despite maintained or reduced weight<\/strong><\/li>\n\n\n\n<li><strong>Muscle loss with simultaneous fat regain after stopping therapy<\/strong><\/li>\n\n\n\n<li><strong>Slower weight loss plateau despite continued medication<\/strong><\/li>\n\n\n\n<li><strong>Declining phase angle indicating cellular health deterioration<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>Tracking these trends is essential for understanding why weight regain is common after stopping GLP-1 therapy and why concurrent muscle preservation strategies are non-negotiable in any complete semaglutide management programme.<\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"aioseo-key-takeaway-early-detection-through-body-composition-109\"><span class=\"ez-toc-section\" id=\"Key_Takeaway_Early_Detection_Through_Body_Composition\"><\/span>Key Takeaway: Early Detection Through Body Composition<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Body composition changes appear before weight gain. Tracking BMR, muscle mass, visceral fat, phase angle, and hydration markers reveals metabolic problems months or years before traditional clinical measures would detect them.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"complete-picture\"><span class=\"ez-toc-section\" id=\"The_Complete_Metabolic_Picture_Beyond_Body_Weight\"><\/span><strong>The Complete Metabolic Picture: Beyond Body Weight<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"686\" src=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-Baseline-Report.webp\" alt=\"\" class=\"wp-image-3318\" srcset=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-Baseline-Report.webp 1024w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-Baseline-Report-300x201.webp 300w, https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/InBody-Baseline-Report-768x515.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><strong>Body weight is only the surface outcome of deeper metabolic processes: energy partitioning, muscle-to-fat balance, visceral fat burden, cellular health, and hydration status. InBody translates these processes into measurable parameters, allowing clinicians to move from assumptions into objective insight.<\/strong><\/p>\n\n\n\n<h4 class=\"wp-block-heading\" id=\"aioseo-body-composition-analysis-with-inbody-provides-114\"><span class=\"ez-toc-section\" id=\"Body_composition_analysis_with_InBody_provides\"><\/span><strong>Body composition analysis with InBody provides:<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h4>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Accurate BMR measurement for personalised nutrition planning during GLP-1 therapy<\/strong><\/li>\n\n\n\n<li><strong>Visceral fat assessment for metabolic disease risk evaluation at each visit<\/strong><\/li>\n\n\n\n<li><strong>Muscle mass tracking to prevent metabolic slowdown and sarcopenia<\/strong><\/li>\n\n\n\n<li><strong>Phase angle monitoring for cellular health across the treatment course<\/strong><\/li>\n\n\n\n<li><strong>Water distribution analysis for detecting inflammation and fluid imbalance<\/strong><\/li>\n<\/ul>\n\n\n\n<p><strong>This comprehensive metabolic assessment is impossible with standard scales or BMI calculations alone, and it is now the clinical standard of care in progressive metabolic medicine globally<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"faq\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span>Frequently Asked Questions<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<div class=\"wp-block-esab-accordion esab-bct1a2b3\" data-mode=\"global\"><div class=\"esab__container\">\n<div class=\"wp-block-esab-accordion-child\"><div class=\"esab__head\" role=\"button\" aria-expanded=\"false\"><div class=\"esab__heading_txt\"><p class=\"esab__heading_tag\">Q. What is Obeda and how does it work?<\/p><\/div><div class=\"esab__icon\"><div class=\"esab__collapse\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m3.5 20.5c-4.7-4.7-4.7-12.3 0-17 4.7-4.7 12.3-4.7 17 0 4.6 4.7 4.6 12.3 0 17-4.7 4.6-12.3 4.6-17 0zm0.9-0.9c4.2 4.2 11 4.2 15.2 0 4.2-4.2 4.2-11 0-15.2-4.2-4.3-11-4.3-15.2 0-4.3 4.2-4.3 11 0 15.2z\"><\/path><path d=\"m11.4 15.9v-3.3h-3.3c-0.3 0-0.6-0.3-0.6-0.6 0-0.4 0.3-0.6 0.6-0.6h3.3v-3.3c0-0.3 0.3-0.6 0.6-0.6 0.3 0 0.6 0.3 0.6 0.6v3.3h3.3c0.3 0 0.6 0.2 0.6 0.6q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2h-3.3v3.3q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2c-0.4 0-0.6-0.3-0.6-0.6z\"><\/path><\/svg> <\/div><div class=\"esab__expand\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m12 24c-6.6 0-12-5.4-12-12 0-6.6 5.4-12 12-12 6.6 0 12 5.4 12 12 0 6.6-5.4 12-12 12zm10.6-12c0-5.9-4.7-10.6-10.6-10.6-5.9 0-10.6 4.7-10.6 10.6 0 5.9 4.7 10.6 10.6 10.6 5.9 0 10.6-4.7 10.6-10.6z\"><\/path><path d=\"m5.6 11.3h12.8v1.4h-12.8z\"><\/path><\/svg> <\/div><\/div><\/div><div class=\"esab__body\">\n<p>Obeda is India&#8217;s first DCGI-approved generic semaglutide injection by Dr Reddy&#8217;s Laboratories. It is a GLP-1 receptor agonist that mimics a natural gut hormone, improving blood sugar control, reducing appetite, and supporting weight loss in adults with type 2 diabetes. It is administered once weekly via a pre-filled subcutaneous pen at \u20b94,200 per month.<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-esab-accordion-child\"><div class=\"esab__head\" role=\"button\" aria-expanded=\"false\"><div class=\"esab__heading_txt\"><p class=\"esab__heading_tag\">Q. Does semaglutide (Obeda) cause muscle loss?<\/p><\/div><div class=\"esab__icon\"><div class=\"esab__collapse\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m3.5 20.5c-4.7-4.7-4.7-12.3 0-17 4.7-4.7 12.3-4.7 17 0 4.6 4.7 4.6 12.3 0 17-4.7 4.6-12.3 4.6-17 0zm0.9-0.9c4.2 4.2 11 4.2 15.2 0 4.2-4.2 4.2-11 0-15.2-4.2-4.3-11-4.3-15.2 0-4.3 4.2-4.3 11 0 15.2z\"><\/path><path d=\"m11.4 15.9v-3.3h-3.3c-0.3 0-0.6-0.3-0.6-0.6 0-0.4 0.3-0.6 0.6-0.6h3.3v-3.3c0-0.3 0.3-0.6 0.6-0.6 0.3 0 0.6 0.3 0.6 0.6v3.3h3.3c0.3 0 0.6 0.2 0.6 0.6q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2h-3.3v3.3q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2c-0.4 0-0.6-0.3-0.6-0.6z\"><\/path><\/svg> <\/div><div class=\"esab__expand\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m12 24c-6.6 0-12-5.4-12-12 0-6.6 5.4-12 12-12 6.6 0 12 5.4 12 12 0 6.6-5.4 12-12 12zm10.6-12c0-5.9-4.7-10.6-10.6-10.6-5.9 0-10.6 4.7-10.6 10.6 0 5.9 4.7 10.6 10.6 10.6 5.9 0 10.6-4.7 10.6-10.6z\"><\/path><path d=\"m5.6 11.3h12.8v1.4h-12.8z\"><\/path><\/svg> <\/div><\/div><\/div><div class=\"esab__body\">\n<p>Research indicates that a portion of the weight lost on GLP-1 drugs like semaglutide may include lean muscle mass, in addition to body fat. The proportion varies by individual, protein intake, physical activity, and dosing. This is why body composition monitoring, rather than weight alone, is recommended for all patients on GLP-1 therapy.<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-esab-accordion-child\"><div class=\"esab__head\" role=\"button\" aria-expanded=\"false\"><div class=\"esab__heading_txt\"><p class=\"esab__heading_tag\">Q. How does InBody help patients on Obeda?<\/p><\/div><div class=\"esab__icon\"><div class=\"esab__collapse\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m3.5 20.5c-4.7-4.7-4.7-12.3 0-17 4.7-4.7 12.3-4.7 17 0 4.6 4.7 4.6 12.3 0 17-4.7 4.6-12.3 4.6-17 0zm0.9-0.9c4.2 4.2 11 4.2 15.2 0 4.2-4.2 4.2-11 0-15.2-4.2-4.3-11-4.3-15.2 0-4.3 4.2-4.3 11 0 15.2z\"><\/path><path d=\"m11.4 15.9v-3.3h-3.3c-0.3 0-0.6-0.3-0.6-0.6 0-0.4 0.3-0.6 0.6-0.6h3.3v-3.3c0-0.3 0.3-0.6 0.6-0.6 0.3 0 0.6 0.3 0.6 0.6v3.3h3.3c0.3 0 0.6 0.2 0.6 0.6q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2h-3.3v3.3q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2c-0.4 0-0.6-0.3-0.6-0.6z\"><\/path><\/svg> <\/div><div class=\"esab__expand\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m12 24c-6.6 0-12-5.4-12-12 0-6.6 5.4-12 12-12 6.6 0 12 5.4 12 12 0 6.6-5.4 12-12 12zm10.6-12c0-5.9-4.7-10.6-10.6-10.6-5.9 0-10.6 4.7-10.6 10.6 0 5.9 4.7 10.6 10.6 10.6 5.9 0 10.6-4.7 10.6-10.6z\"><\/path><path d=\"m5.6 11.3h12.8v1.4h-12.8z\"><\/path><\/svg> <\/div><\/div><\/div><div class=\"esab__body\">\n<p>InBody body composition analysers measure skeletal muscle mass, body fat percentage, visceral fat level, phase angle, BMR, and water distribution, giving clinicians a precise, objective picture of whether a patient on semaglutide is losing fat (the goal) or muscle (the risk). Each scan takes under 60 seconds and is completely non-invasive.<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-esab-accordion-child\"><div class=\"esab__head\" role=\"button\" aria-expanded=\"false\"><div class=\"esab__heading_txt\"><p class=\"esab__heading_tag\">Q. How often should InBody scans be done during GLP-1 therapy?<\/p><\/div><div class=\"esab__icon\"><div class=\"esab__collapse\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m3.5 20.5c-4.7-4.7-4.7-12.3 0-17 4.7-4.7 12.3-4.7 17 0 4.6 4.7 4.6 12.3 0 17-4.7 4.6-12.3 4.6-17 0zm0.9-0.9c4.2 4.2 11 4.2 15.2 0 4.2-4.2 4.2-11 0-15.2-4.2-4.3-11-4.3-15.2 0-4.3 4.2-4.3 11 0 15.2z\"><\/path><path d=\"m11.4 15.9v-3.3h-3.3c-0.3 0-0.6-0.3-0.6-0.6 0-0.4 0.3-0.6 0.6-0.6h3.3v-3.3c0-0.3 0.3-0.6 0.6-0.6 0.3 0 0.6 0.3 0.6 0.6v3.3h3.3c0.3 0 0.6 0.2 0.6 0.6q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2h-3.3v3.3q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2c-0.4 0-0.6-0.3-0.6-0.6z\"><\/path><\/svg> <\/div><div class=\"esab__expand\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m12 24c-6.6 0-12-5.4-12-12 0-6.6 5.4-12 12-12 6.6 0 12 5.4 12 12 0 6.6-5.4 12-12 12zm10.6-12c0-5.9-4.7-10.6-10.6-10.6-5.9 0-10.6 4.7-10.6 10.6 0 5.9 4.7 10.6 10.6 10.6 5.9 0 10.6-4.7 10.6-10.6z\"><\/path><path d=\"m5.6 11.3h12.8v1.4h-12.8z\"><\/path><\/svg> <\/div><\/div><\/div><div class=\"esab__body\">\n<p>Best practice: A baseline scan before starting Obeda, a check at 4\u20136 weeks during dose escalation, monthly scans throughout active treatment, and a comprehensive 6-month outcome review comparing all metrics to baseline.<\/p>\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-esab-accordion-child\"><div class=\"esab__head\" role=\"button\" aria-expanded=\"false\"><div class=\"esab__heading_txt\"><p class=\"esab__heading_tag\">Q. Which InBody model suits a diabetes or endocrinology clinic?<\/p><\/div><div class=\"esab__icon\"><div class=\"esab__collapse\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m3.5 20.5c-4.7-4.7-4.7-12.3 0-17 4.7-4.7 12.3-4.7 17 0 4.6 4.7 4.6 12.3 0 17-4.7 4.6-12.3 4.6-17 0zm0.9-0.9c4.2 4.2 11 4.2 15.2 0 4.2-4.2 4.2-11 0-15.2-4.2-4.3-11-4.3-15.2 0-4.3 4.2-4.3 11 0 15.2z\"><\/path><path d=\"m11.4 15.9v-3.3h-3.3c-0.3 0-0.6-0.3-0.6-0.6 0-0.4 0.3-0.6 0.6-0.6h3.3v-3.3c0-0.3 0.3-0.6 0.6-0.6 0.3 0 0.6 0.3 0.6 0.6v3.3h3.3c0.3 0 0.6 0.2 0.6 0.6q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2h-3.3v3.3q0 0.2-0.2 0.4-0.2 0.2-0.4 0.2c-0.4 0-0.6-0.3-0.6-0.6z\"><\/path><\/svg> <\/div><div class=\"esab__expand\"> <svg version=\"1.2\" viewBox=\"0 0 24 24\" width=\"24\" height=\"24\"><path fill-rule=\"evenodd\" d=\"m12 24c-6.6 0-12-5.4-12-12 0-6.6 5.4-12 12-12 6.6 0 12 5.4 12 12 0 6.6-5.4 12-12 12zm10.6-12c0-5.9-4.7-10.6-10.6-10.6-5.9 0-10.6 4.7-10.6 10.6 0 5.9 4.7 10.6 10.6 10.6 5.9 0 10.6-4.7 10.6-10.6z\"><\/path><path d=\"m5.6 11.3h12.8v1.4h-12.8z\"><\/path><\/svg> <\/div><\/div><\/div><div class=\"esab__body\">\n<p>InBody India offers several models for clinical settings. The InBody 570 is ideal for most outpatient diabetes and metabolic clinics, providing full body composition analysis, including visceral fat and phase angle. The InBody 970 is suited for research-grade clinical programmes. Contact InBody India for a product consultation tailored to your practice.<\/p>\n<\/div><\/div>\n<\/div><\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"conclusion\"><span class=\"ez-toc-section\" id=\"Conclusion_Indias_GLP-1_Era_Needs_a_Body_Composition_Partner\"><\/span><strong>Conclusion: India&#8217;s GLP-1 Era Needs a Body Composition Partner<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><strong>Obeda&#8217;s launch marks a turning point in how India manages metabolic disease. For the first time, a clinically validated, DCGI-approved, affordable GLP-1 therapy is within reach for millions of Indians who need it. That is genuinely significant progress.<\/strong><\/p>\n\n\n\n<p><strong>But the clinical responsibility that comes with wider GLP-1 adoption is equally significant. Weight loss is not the same as fat loss. A falling number on the scale is not always a sign of better metabolic health, especially if what is falling includes the muscle that patients need for long-term metabolic function, glucose disposal, and quality of life.<\/strong><\/p>\n\n\n\n<p><strong>Body composition analysis with InBody translates the promise of semaglutide therapy into measurable, manageable, objective outcomes at every step of the treatment journey.<\/strong><\/p>\n\n\n\n<p><strong>As India enters its GLP-1 era, the clinics that lead won&#8217;t just prescribe the injection. They&#8217;ll measure what truly changes inside.<\/strong><\/p>\n\n\n\n<p><strong>Medical Disclaimer:<\/strong> This blog is intended for healthcare professionals and is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. Obeda (semaglutide) is a prescription medication; all clinical decisions must be made by qualified healthcare providers based on individual patient assessment. InBody results should be interpreted in conjunction with a full clinical evaluation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"aioseo-references-further-reading-140\"><span class=\"ez-toc-section\" id=\"References_Further_Reading\"><\/span>References &amp; Further Reading<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Dr. Reddy\u2019s Official Announcement (March 2026):<\/strong> <a href=\"https:\/\/www.indianpharmapost.com\/news\/dr-reddys-laboratories-launches-indias-first-dcgi-approved-semaglutide-injection-obeda-for-type-2-diabetes-19429\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Reddy&#8217;s Laboratories launches India&#8217;s first DCGI-approved Semaglutide injection &#8216;Obeda&#8217;<\/a><\/li>\n\n\n\n<li><strong>DCGI \/ CDSCO Approval Tracking:<\/strong> <a href=\"https:\/\/cdsco.gov.in\/opencms\/opencms\/en\/Home\/\" target=\"_blank\" rel=\"noreferrer noopener\">Central Drugs Standard Control Organisation (CDSCO)<\/a> \u2014 <em>Used to verify the generic drug approval registry for 2026.<\/em><\/li>\n\n\n\n<li><strong>ICMR-INDIAB Study (PIB):<\/strong> <a href=\"https:\/\/www.pib.gov.in\/PressReleasePage.aspx?PRID=1955800\" target=\"_blank\" rel=\"noreferrer noopener\">Prevalence of Diabetes and Prediabetes in India (101 Million Adults)<\/a><\/li>\n\n\n\n<li><strong>The Lancet Diabetes &amp; Endocrinology:<\/strong> <a href=\"https:\/\/www.thelancet.com\/journals\/landia\/article\/PIIS2213-8587(23)00119-5\/fulltext\" target=\"_blank\" rel=\"noreferrer noopener\">Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study<\/a><\/li>\n\n\n\n<li><strong>The STEP 1 Trial (NEJM):<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33567185\/\" target=\"_blank\" rel=\"noreferrer noopener\">Once-Weekly Semaglutide in Adults with Overweight or Obesity<\/a> \u2014 <em>The primary clinical trial demonstrating weight loss efficacy.<\/em><\/li>\n\n\n\n<li><strong>Lean Mass Loss Review (Obesity Reviews):<\/strong> <a href=\"https:\/\/www.researchgate.net\/publication\/379891929_A_systematic_review_of_the_effect_of_semaglutide_on_Lean_Mass_insights_from_clinical_trials\" target=\"_blank\" rel=\"noreferrer noopener\">A systematic review of the effect of semaglutide on Lean Mass<\/a> (Bikou O, et al.)<\/li>\n\n\n\n<li><strong>Muscle Mass &amp; Metabolic Rate (AJCN):<\/strong> <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/10908311\/\" target=\"_blank\" rel=\"noreferrer noopener\">Skeletal muscle mass and distribution in 468 men and women<\/a> (Janssen I, et al., 2000)<\/li>\n\n\n\n<li><strong>InBody USA White Paper:<\/strong> <a href=\"https:\/\/inbodyusa.com\/blogs\/inbodyblog\/body-fat-percentage-chart\/\" target=\"_blank\" rel=\"noreferrer noopener\">Understanding Body Fat &amp; Muscle Categories<\/a> \u2014 <em>Explains why BMI is insufficient and how Direct Segmental Multi-frequency BIA (DSM-BIA) works.<\/em><\/li>\n\n\n\n<li><strong>Healthline &#8211; Muscle Loss &amp; Ozempic\/Wegovy:<\/strong> <a href=\"https:\/\/www.healthline.com\/health-news\/ozempic-muscle-mass-loss\" target=\"_blank\" rel=\"noreferrer noopener\">What to Know About Muscle Loss While Taking Semaglutide<\/a><\/li>\n<\/ol>\n\n\n\n<figure class=\"wp-block-image aligncenter is-resized\"><a class=\"custom-logo-link\" href=\"https:\/\/www.inbody.in\/blog\/\"><img decoding=\"async\" src=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/cropped-CI_Main_Version_RGB.png\" alt=\"Inbody Blog\" style=\"aspect-ratio:3.317725752508361;width:331px;height:auto\"\/><\/a><\/figure>\n\n\n\n<p class=\"has-text-align-center\"><a href=\"https:\/\/www.inbody.in\/support\/Locations.php\"><strong>Find an InBody Scanner Near You<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>How Body Composition Monitoring Completes the Semaglutide Story in India The Problem: Weight Doesn&#8217;t Tell the Whole Story GLP-1 therapy conversations typically focus on blood sugar control and body weight reduction. This simplified framework misses what actually governs how your body responds to semaglutide: changes in muscle mass, fat distribution, and cellular metabolic health. The [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3170","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"blocksy_meta":[],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Obeda Is Here, but What Happens to Your Muscles? - Inbody Blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Obeda Is Here, but What Happens to Your Muscles? - Inbody Blog\" \/>\n<meta property=\"og:description\" content=\"How Body Composition Monitoring Completes the Semaglutide Story in India The Problem: Weight Doesn&#8217;t Tell the Whole Story GLP-1 therapy conversations typically focus on blood sugar control and body weight reduction. This simplified framework misses what actually governs how your body responds to semaglutide: changes in muscle mass, fat distribution, and cellular metabolic health. The [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles\" \/>\n<meta property=\"og:site_name\" content=\"Inbody Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/inbodyindia\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-13T11:38:25+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-16T04:32:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"612\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Team InBody\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Team InBody\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"12 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles\"},\"author\":{\"name\":\"Team InBody\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#\\\/schema\\\/person\\\/b3308d7e4bfa36467e1295daf3e7f224\"},\"headline\":\"Obeda Is Here, but What Happens to Your Muscles?\",\"datePublished\":\"2026-04-13T11:38:25+00:00\",\"dateModified\":\"2026-04-16T04:32:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles\"},\"wordCount\":2349,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Doctor-explaining-InBody-results-sheet.webp\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles\",\"url\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles\",\"name\":\"Obeda Is Here, but What Happens to Your Muscles? - Inbody Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Doctor-explaining-InBody-results-sheet.webp\",\"datePublished\":\"2026-04-13T11:38:25+00:00\",\"dateModified\":\"2026-04-16T04:32:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage\",\"url\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Doctor-explaining-InBody-results-sheet.webp\",\"contentUrl\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/Doctor-explaining-InBody-results-sheet.webp\",\"width\":1024,\"height\":612},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/obeda-is-here-but-what-happens-to-your-muscles#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Obeda Is Here, but What Happens to Your Muscles?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/\",\"name\":\"Inbody Blog\",\"description\":\"See What You&#039;re Made Of.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#organization\",\"name\":\"Inbody Blog\",\"url\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/cropped-CI_Main_Version_RGB.png\",\"contentUrl\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/cropped-CI_Main_Version_RGB.png\",\"width\":554,\"height\":167,\"caption\":\"Inbody Blog\"},\"image\":{\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/inbodyindia\\\/\",\"https:\\\/\\\/www.instagram.com\\\/inbodyindia\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/#\\\/schema\\\/person\\\/b3308d7e4bfa36467e1295daf3e7f224\",\"name\":\"Team InBody\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9f5eb8c474669b2978af46cf72a4e9d2cb6d3e6e77535df64d3b6eaf4945c7c?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9f5eb8c474669b2978af46cf72a4e9d2cb6d3e6e77535df64d3b6eaf4945c7c?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a9f5eb8c474669b2978af46cf72a4e9d2cb6d3e6e77535df64d3b6eaf4945c7c?s=96&d=mm&r=g\",\"caption\":\"Team InBody\"},\"url\":\"https:\\\/\\\/www.inbody.in\\\/blog\\\/author\\\/team-inbody\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Obeda Is Here, but What Happens to Your Muscles? - Inbody Blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles","og_locale":"en_US","og_type":"article","og_title":"Obeda Is Here, but What Happens to Your Muscles? - Inbody Blog","og_description":"How Body Composition Monitoring Completes the Semaglutide Story in India The Problem: Weight Doesn&#8217;t Tell the Whole Story GLP-1 therapy conversations typically focus on blood sugar control and body weight reduction. This simplified framework misses what actually governs how your body responds to semaglutide: changes in muscle mass, fat distribution, and cellular metabolic health. The [&hellip;]","og_url":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles","og_site_name":"Inbody Blog","article_publisher":"https:\/\/www.facebook.com\/inbodyindia\/","article_published_time":"2026-04-13T11:38:25+00:00","article_modified_time":"2026-04-16T04:32:06+00:00","og_image":[{"width":1024,"height":612,"url":"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp","type":"image\/webp"}],"author":"Team InBody","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Team InBody","Est. reading time":"12 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#article","isPartOf":{"@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles"},"author":{"name":"Team InBody","@id":"https:\/\/www.inbody.in\/blog\/#\/schema\/person\/b3308d7e4bfa36467e1295daf3e7f224"},"headline":"Obeda Is Here, but What Happens to Your Muscles?","datePublished":"2026-04-13T11:38:25+00:00","dateModified":"2026-04-16T04:32:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles"},"wordCount":2349,"commentCount":0,"publisher":{"@id":"https:\/\/www.inbody.in\/blog\/#organization"},"image":{"@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage"},"thumbnailUrl":"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles","url":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles","name":"Obeda Is Here, but What Happens to Your Muscles? - Inbody Blog","isPartOf":{"@id":"https:\/\/www.inbody.in\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage"},"image":{"@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage"},"thumbnailUrl":"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp","datePublished":"2026-04-13T11:38:25+00:00","dateModified":"2026-04-16T04:32:06+00:00","breadcrumb":{"@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#primaryimage","url":"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp","contentUrl":"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/04\/Doctor-explaining-InBody-results-sheet.webp","width":1024,"height":612},{"@type":"BreadcrumbList","@id":"https:\/\/www.inbody.in\/blog\/obeda-is-here-but-what-happens-to-your-muscles#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.inbody.in\/blog\/"},{"@type":"ListItem","position":2,"name":"Obeda Is Here, but What Happens to Your Muscles?"}]},{"@type":"WebSite","@id":"https:\/\/www.inbody.in\/blog\/#website","url":"https:\/\/www.inbody.in\/blog\/","name":"Inbody Blog","description":"See What You&#039;re Made Of.","publisher":{"@id":"https:\/\/www.inbody.in\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.inbody.in\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.inbody.in\/blog\/#organization","name":"Inbody Blog","url":"https:\/\/www.inbody.in\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.inbody.in\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/cropped-CI_Main_Version_RGB.png","contentUrl":"https:\/\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/cropped-CI_Main_Version_RGB.png","width":554,"height":167,"caption":"Inbody Blog"},"image":{"@id":"https:\/\/www.inbody.in\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/inbodyindia\/","https:\/\/www.instagram.com\/inbodyindia"]},{"@type":"Person","@id":"https:\/\/www.inbody.in\/blog\/#\/schema\/person\/b3308d7e4bfa36467e1295daf3e7f224","name":"Team InBody","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a9f5eb8c474669b2978af46cf72a4e9d2cb6d3e6e77535df64d3b6eaf4945c7c?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a9f5eb8c474669b2978af46cf72a4e9d2cb6d3e6e77535df64d3b6eaf4945c7c?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a9f5eb8c474669b2978af46cf72a4e9d2cb6d3e6e77535df64d3b6eaf4945c7c?s=96&d=mm&r=g","caption":"Team InBody"},"url":"https:\/\/www.inbody.in\/blog\/author\/team-inbody"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":1004,"url":"https:\/\/www.inbody.in\/blog\/glp-1-weight-loss-drugs","url_meta":{"origin":3170,"position":0},"title":"Urgent Reasons Your GLP-1 is Secretly Sabotaging Your Health","author":"Team InBody","date":"May 13, 2025","format":false,"excerpt":"There\u2019s no denying it GLP-1 drugs like Ozempic, Wegovy, and others have completely transformed the weight loss landscape. With so many people now using these medications, the real question becomes: what\u2019s actually happening inside your body when you\u2019re on them? It\u2019s not just about the number on the scale it\u2019s\u2026","rel":"","context":"In &quot;Body Composition&quot;","block_context":{"text":"Body Composition","link":"https:\/\/www.inbody.in\/blog\/category\/body"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/Orange-White-and-Yellow-White-GLP-1-pills.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/Orange-White-and-Yellow-White-GLP-1-pills.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/Orange-White-and-Yellow-White-GLP-1-pills.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/Orange-White-and-Yellow-White-GLP-1-pills.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/Orange-White-and-Yellow-White-GLP-1-pills.webp?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/05\/Orange-White-and-Yellow-White-GLP-1-pills.webp?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1650,"url":"https:\/\/www.inbody.in\/blog\/this-diwali-let-your-health-shine-brighter-with-the-new-inbody-dial-h30","url_meta":{"origin":3170,"position":1},"title":"How This Absolute Best Biological Strategy Destroys Stubborn Fat Growth","author":"inbody_webdev","date":"October 17, 2025","format":false,"excerpt":"Every Diwali, we clean our homes, buy new clothes, and light up our spaces with joy, but how often do we think about lighting up our health? As the festival of lights approaches, it\u2019s time to celebrate a different kind of glow, the one that comes from a healthy, balanced\u2026","rel":"","context":"In &quot;Body Composition&quot;","block_context":{"text":"Body Composition","link":"https:\/\/www.inbody.in\/blog\/category\/body"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/10\/Home-Workouts.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/10\/Home-Workouts.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/10\/Home-Workouts.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/10\/Home-Workouts.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/10\/Home-Workouts.webp?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":1175,"url":"https:\/\/www.inbody.in\/blog\/what-is-body-composition","url_meta":{"origin":3170,"position":2},"title":"How This Absolute Best Biological Strategy Defeats Hidden Fat Growth","author":"inbody_webdev","date":"June 20, 2025","format":"chat","excerpt":"-Understanding What Your Body is Made Of- Why the Number on the Scale Isn\u2019t the Whole StoryWhen people think about getting fit, they usually focus on their weight first. We\u2019ve all stepped on the scale hoping for a certain number. But here\u2019s the thing: that number doesn\u2019t really tell you\u2026","rel":"","context":"In &quot;Body Composition&quot;","block_context":{"text":"Body Composition","link":"https:\/\/www.inbody.in\/blog\/category\/body"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/06\/InBody-Test-scaled.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/06\/InBody-Test-scaled.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/06\/InBody-Test-scaled.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/06\/InBody-Test-scaled.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/06\/InBody-Test-scaled.webp?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2025\/06\/InBody-Test-scaled.webp?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":1797,"url":"https:\/\/www.inbody.in\/blog\/understanding-metabolism-how-body-composition-analysis-reveals-whats-really-happening","url_meta":{"origin":3170,"position":3},"title":"Urgent Reasons Your Current Metabolism is Secretly Sabotaging Your Goals","author":"inbody_webdev","date":"January 7, 2026","format":false,"excerpt":"The Problem: Weight Doesn't Tell the Whole Story Weight management conversations typically focus on \"calories in versus calories out.\" This oversimplified framework misses what actually governs how your body stores energy, burns fuel, and adapts over time. The real driver is metabolism, a complex biological system that can now be\u2026","rel":"","context":"Similar post","block_context":{"text":"Similar post","link":""},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/01\/InBody-970S-result-sheet.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/01\/InBody-970S-result-sheet.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/01\/InBody-970S-result-sheet.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/01\/InBody-970S-result-sheet.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2026\/01\/InBody-970S-result-sheet.webp?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":40,"url":"https:\/\/www.inbody.in\/blog\/are-you-a-fitness-ista","url_meta":{"origin":3170,"position":4},"title":"The Truth About Fitness That BMI Will Never Tell You","author":"Team InBody","date":"October 31, 2019","format":false,"excerpt":"Fitness is not a number on a scale. Yet most of us still judge our health by weight alone. In fact, BMI, the most widely used fitness metric in the world, was never designed to measure fitness at all. Furthermore, it cannot distinguish fat from muscle, and it has no\u2026","rel":"","context":"In &quot;Body Composition&quot;","block_context":{"text":"Body Composition","link":"https:\/\/www.inbody.in\/blog\/category\/body"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2019\/10\/Good-Health-770-1.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2019\/10\/Good-Health-770-1.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2019\/10\/Good-Health-770-1.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2019\/10\/Good-Health-770-1.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":356,"url":"https:\/\/www.inbody.in\/blog\/is-body-composition-analysis-a-serious-tool-for-medical-diagnosis","url_meta":{"origin":3170,"position":5},"title":"The Absolute Best Way to Guarantee Success: 7 Proven Truths of Routine Body Composition Tracking","author":"Team InBody","date":"March 9, 2021","format":false,"excerpt":"If you are serious about health outcomes, there is one habit that separates people who achieve lasting results from those who do not. It is not the diet they follow, the exercise routine they choose, or the supplements they take. It is whether they measure their progress in a way\u2026","rel":"","context":"In &quot;Body Composition&quot;","block_context":{"text":"Body Composition","link":"https:\/\/www.inbody.in\/blog\/category\/body"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2021\/03\/Man-showing-InBody-results-sheet.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2021\/03\/Man-showing-InBody-results-sheet.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2021\/03\/Man-showing-InBody-results-sheet.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2021\/03\/Man-showing-InBody-results-sheet.webp?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.inbody.in\/blog\/wp-content\/uploads\/2021\/03\/Man-showing-InBody-results-sheet.webp?resize=1050%2C600&ssl=1 3x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/posts\/3170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/comments?post=3170"}],"version-history":[{"count":5,"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/posts\/3170\/revisions"}],"predecessor-version":[{"id":3334,"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/posts\/3170\/revisions\/3334"}],"wp:attachment":[{"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/media?parent=3170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/categories?post=3170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inbody.in\/blog\/wp-json\/wp\/v2\/tags?post=3170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}